

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | keratinization (GO:0031424) | 6.82011718 |
| 2 | hemidesmosome assembly (GO:0031581) | 6.37364293 |
| 3 | establishment of skin barrier (GO:0061436) | 5.00532159 |
| 4 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.94815243 |
| 5 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.67078699 |
| 6 | negative regulation of keratinocyte proliferation (GO:0010839) | 4.60319550 |
| 7 | regulation of water loss via skin (GO:0033561) | 4.49152977 |
| 8 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.44683065 |
| 9 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.44683065 |
| 10 | modulation by symbiont of host immune response (GO:0052553) | 4.44683065 |
| 11 | positive regulation by symbiont of host defense response (GO:0052509) | 4.44683065 |
| 12 | modulation by symbiont of host defense response (GO:0052031) | 4.44683065 |
| 13 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.44683065 |
| 14 | keratinocyte proliferation (GO:0043616) | 4.40941204 |
| 15 | gap junction assembly (GO:0016264) | 4.24784254 |
| 16 | low-density lipoprotein particle clearance (GO:0034383) | 3.88617240 |
| 17 | macrophage activation involved in immune response (GO:0002281) | 3.76197350 |
| 18 | neutrophil activation involved in immune response (GO:0002283) | 3.75576660 |
| 19 | keratinocyte differentiation (GO:0030216) | 3.74935429 |
| 20 | response to muramyl dipeptide (GO:0032495) | 3.66359634 |
| 21 | COPI coating of Golgi vesicle (GO:0048205) | 3.64419071 |
| 22 | Golgi transport vesicle coating (GO:0048200) | 3.64419071 |
| 23 | growth hormone receptor signaling pathway (GO:0060396) | 3.59525957 |
| 24 | chondrocyte proliferation (GO:0035988) | 3.57745418 |
| 25 | response to peptidoglycan (GO:0032494) | 3.48051985 |
| 26 | microglial cell activation (GO:0001774) | 3.43314340 |
| 27 | regulation of keratinocyte proliferation (GO:0010837) | 3.41541364 |
| 28 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.41194236 |
| 29 | molting cycle (GO:0042303) | 3.40352196 |
| 30 | hair cycle (GO:0042633) | 3.40352196 |
| 31 | polarized epithelial cell differentiation (GO:0030859) | 3.33174706 |
| 32 | anterior/posterior axis specification, embryo (GO:0008595) | 3.25579893 |
| 33 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.24161568 |
| 34 | negative regulation of fibrinolysis (GO:0051918) | 3.23752917 |
| 35 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.20210878 |
| 36 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.19862401 |
| 37 | regulation of hippo signaling (GO:0035330) | 3.16428499 |
| 38 | NIK/NF-kappaB signaling (GO:0038061) | 3.13694499 |
| 39 | negative regulation of lipid storage (GO:0010888) | 3.13652731 |
| 40 | cellular response to growth hormone stimulus (GO:0071378) | 3.13643290 |
| 41 | positive regulation of interferon-alpha production (GO:0032727) | 3.13546793 |
| 42 | intestinal cholesterol absorption (GO:0030299) | 3.13168700 |
| 43 | multicellular organismal water homeostasis (GO:0050891) | 3.11672637 |
| 44 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.10932605 |
| 45 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.09160202 |
| 46 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.07621714 |
| 47 | keratinocyte development (GO:0003334) | 3.07394175 |
| 48 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.06713468 |
| 49 | regulation of cholesterol storage (GO:0010885) | 3.05822511 |
| 50 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.04953299 |
| 51 | epidermal cell differentiation (GO:0009913) | 3.04951503 |
| 52 | T-helper 1 type immune response (GO:0042088) | 3.02139173 |
| 53 | granulocyte activation (GO:0036230) | 3.01606537 |
| 54 | epidermis development (GO:0008544) | 3.01223150 |
| 55 | response to lipoprotein particle (GO:0055094) | 3.01182712 |
| 56 | regulation of fibrinolysis (GO:0051917) | 3.00165623 |
| 57 | skin morphogenesis (GO:0043589) | 2.97644192 |
| 58 | positive regulation of interleukin-12 production (GO:0032735) | 2.97048293 |
| 59 | interleukin-1-mediated signaling pathway (GO:0070498) | 2.95112599 |
| 60 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.93295634 |
| 61 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.93295634 |
| 62 | regulation of interferon-alpha production (GO:0032647) | 2.93116450 |
| 63 | positive regulation of antigen processing and presentation (GO:0002579) | 2.91516004 |
| 64 | neutrophil activation (GO:0042119) | 2.90943564 |
| 65 | atrioventricular valve morphogenesis (GO:0003181) | 2.90927190 |
| 66 | positive regulation of heat generation (GO:0031652) | 2.90671011 |
| 67 | regulation of gonadotropin secretion (GO:0032276) | 2.88733606 |
| 68 | positive regulation of p38MAPK cascade (GO:1900745) | 2.81444741 |
| 69 | cellular glucuronidation (GO:0052695) | 2.80217512 |
| 70 | macrophage activation (GO:0042116) | 2.80187396 |
| 71 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.78545561 |
| 72 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.78044063 |
| 73 | response to host immune response (GO:0052572) | 2.78044063 |
| 74 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.77217229 |
| 75 | notochord development (GO:0030903) | 2.75939545 |
| 76 | ectoderm development (GO:0007398) | 2.75771233 |
| 77 | desmosome organization (GO:0002934) | 2.75688068 |
| 78 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.75580752 |
| 79 | cytokine secretion (GO:0050663) | 2.74628525 |
| 80 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.65616831 |
| 81 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.65587893 |
| 82 | glucuronate metabolic process (GO:0019585) | 2.64381343 |
| 83 | uronic acid metabolic process (GO:0006063) | 2.64381343 |
| 84 | embryonic foregut morphogenesis (GO:0048617) | 2.64344686 |
| 85 | positive regulation of macrophage cytokine production (GO:0060907) | 2.63877949 |
| 86 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.63841827 |
| 87 | apoptotic cell clearance (GO:0043277) | 2.63611291 |
| 88 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.63597827 |
| 89 | nodal signaling pathway (GO:0038092) | 2.63403166 |
| 90 | intestinal absorption (GO:0050892) | 2.62688583 |
| 91 | cell migration involved in sprouting angiogenesis (GO:0002042) | 2.62406327 |
| 92 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.61599088 |
| 93 | regulation of plasminogen activation (GO:0010755) | 2.61559741 |
| 94 | epithelial cell-cell adhesion (GO:0090136) | 2.61169605 |
| 95 | cell adhesion mediated by integrin (GO:0033627) | 2.60765811 |
| 96 | reactive oxygen species biosynthetic process (GO:1903409) | 2.60717478 |
| 97 | positive regulation of cholesterol efflux (GO:0010875) | 2.60456080 |
| 98 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.60245555 |
| 99 | respiratory burst (GO:0045730) | 2.59816134 |
| 100 | macroautophagy (GO:0016236) | 2.59254105 |
| 101 | I-kappaB phosphorylation (GO:0007252) | 2.58945747 |
| 102 | intestinal epithelial cell development (GO:0060576) | 2.58862057 |
| 103 | regulation of cell proliferation involved in kidney development (GO:1901722) | 2.57870946 |
| 104 | regulation of cardioblast differentiation (GO:0051890) | 2.57125486 |
| 105 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.56713210 |
| 106 | water homeostasis (GO:0030104) | 2.56657130 |
| 107 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.53699045 |
| 108 | response to host (GO:0075136) | 2.53699045 |
| 109 | response to host defenses (GO:0052200) | 2.53699045 |
| 110 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.52937949 |
| 111 | intermediate filament organization (GO:0045109) | 2.52383350 |
| 112 | regulation of fever generation (GO:0031620) | 2.52179198 |
| 113 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.52076850 |
| 114 | negative regulation of protein activation cascade (GO:2000258) | 2.51910105 |
| 115 | positive regulation of chemokine production (GO:0032722) | 2.51607858 |
| 116 | regulation of protein activation cascade (GO:2000257) | 2.51376852 |
| 117 | establishment of tissue polarity (GO:0007164) | 2.50747292 |
| 118 | establishment of planar polarity (GO:0001736) | 2.50747292 |
| 119 | cellular response to follicle-stimulating hormone stimulus (GO:0071372) | 2.50290114 |
| 120 | negative regulation of interleukin-17 production (GO:0032700) | 2.48983842 |
| 121 | cardiac right ventricle morphogenesis (GO:0003215) | 2.48673852 |
| 122 | eosinophil chemotaxis (GO:0048245) | 2.47404712 |
| 123 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.47257646 |
| 124 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.45682895 |
| 125 | natural killer cell mediated immunity (GO:0002228) | 2.45682895 |
| 126 | regulation of interleukin-12 production (GO:0032655) | 2.44237243 |
| 127 | protein carboxylation (GO:0018214) | 2.44227834 |
| 128 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.44227834 |
| 129 | regulation of Wnt signaling pathway involved in heart development (GO:0003307) | 2.42649332 |
| 130 | neural crest cell development (GO:0014032) | 2.42288818 |
| 131 | positive regulation of interferon-beta production (GO:0032728) | 2.42185631 |
| 132 | regulation of antigen processing and presentation (GO:0002577) | 2.42056391 |
| 133 | positive regulation of interleukin-6 production (GO:0032755) | 2.41887674 |
| 134 | positive regulation of male gonad development (GO:2000020) | 2.41807896 |
| 135 | detection of molecule of bacterial origin (GO:0032490) | 2.40759734 |
| 136 | regulation of complement activation (GO:0030449) | 2.39795704 |
| 137 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.39033184 |
| 138 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.38998197 |
| 139 | wound healing, spreading of epidermal cells (GO:0035313) | 2.38715092 |
| 140 | L-phenylalanine metabolic process (GO:0006558) | 2.37888303 |
| 141 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.37888303 |
| 142 | negative regulation of lipase activity (GO:0060192) | 2.37521735 |
| 143 | cysteine metabolic process (GO:0006534) | 2.35660187 |
| 144 | smooth muscle tissue development (GO:0048745) | 2.35153138 |
| 145 | cellular zinc ion homeostasis (GO:0006882) | 2.34806151 |
| 146 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.34282011 |
| 147 | regulation of heat generation (GO:0031650) | 2.34157248 |
| 148 | fibrinolysis (GO:0042730) | 2.33979348 |
| 149 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.33345558 |
| 150 | response to follicle-stimulating hormone (GO:0032354) | 2.32982260 |
| 151 | L-phenylalanine catabolic process (GO:0006559) | 2.32274005 |
| 152 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.32274005 |
| 153 | regulation of cholesterol homeostasis (GO:2000188) | 2.32183912 |
| 154 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 2.31963361 |
| 155 | myeloid dendritic cell differentiation (GO:0043011) | 2.31636111 |
| 156 | L-serine transport (GO:0015825) | 2.31347081 |
| 157 | positive regulation of sterol transport (GO:0032373) | 2.31324880 |
| 158 | positive regulation of cholesterol transport (GO:0032376) | 2.31324880 |
| 159 | high-density lipoprotein particle remodeling (GO:0034375) | 2.30682976 |
| 160 | negative regulation of bone resorption (GO:0045779) | 2.30624506 |
| 161 | regulation of podosome assembly (GO:0071801) | 2.30523050 |
| 162 | positive regulation of glomerulus development (GO:0090193) | 2.30228199 |
| 163 | activin receptor signaling pathway (GO:0032924) | 2.29672897 |
| 164 | male genitalia development (GO:0030539) | 2.28929345 |
| 165 | regulation of chemokine biosynthetic process (GO:0045073) | 2.28737184 |
| 166 | cellular response to vitamin D (GO:0071305) | 2.28460685 |
| 167 | pattern specification involved in kidney development (GO:0061004) | 2.28394153 |
| 168 | cellular response to vitamin (GO:0071295) | 2.28156518 |
| 169 | exocrine pancreas development (GO:0031017) | 2.28110073 |
| 170 | hippo signaling (GO:0035329) | 2.28080082 |
| 171 | sequestering of metal ion (GO:0051238) | 2.27058727 |
| 172 | response to nitrosative stress (GO:0051409) | 2.26919382 |
| 173 | positive regulation of leukocyte degranulation (GO:0043302) | 2.26825637 |
| 174 | dorsal/ventral axis specification (GO:0009950) | 2.26678962 |
| 175 | myeloid cell activation involved in immune response (GO:0002275) | 2.25931000 |
| 176 | positive regulation of type 2 immune response (GO:0002830) | 2.24977276 |
| 177 | peptide hormone processing (GO:0016486) | 2.24926261 |
| 178 | immunoglobulin mediated immune response (GO:0016064) | 2.24338278 |
| 179 | cellular response to zinc ion (GO:0071294) | 2.23882042 |
| 180 | cellular response to interferon-alpha (GO:0035457) | 2.23793632 |
| 181 | cholesterol biosynthetic process (GO:0006695) | 2.22984661 |
| 182 | regulation of mesoderm development (GO:2000380) | 2.22207129 |
| 183 | epithelial tube branching involved in lung morphogenesis (GO:0060441) | 2.21909478 |
| 184 | female gonad development (GO:0008585) | 2.21071746 |
| 185 | negative regulation of complement activation (GO:0045916) | 2.20914139 |
| 186 | regulation of transforming growth factor beta production (GO:0071634) | 2.19123745 |
| 187 | plasma lipoprotein particle clearance (GO:0034381) | 2.19057792 |
| 188 | lateral sprouting from an epithelium (GO:0060601) | 2.18121259 |
| 189 | ER overload response (GO:0006983) | 2.17428068 |
| 190 | midgut development (GO:0007494) | 2.16425890 |
| 191 | cell-substrate junction assembly (GO:0007044) | 2.16076674 |
| 192 | drug transmembrane transport (GO:0006855) | 2.15428831 |
| 193 | chemical homeostasis within a tissue (GO:0048875) | 2.13380336 |
| 194 | endocardial cushion development (GO:0003197) | 2.12968083 |
| 195 | sterol biosynthetic process (GO:0016126) | 2.11980092 |
| 196 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.11798652 |
| 197 | macromolecular complex remodeling (GO:0034367) | 2.11655371 |
| 198 | plasma lipoprotein particle remodeling (GO:0034369) | 2.11655371 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 6.01821236 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.77155722 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.49870445 |
| 4 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 3.35105694 |
| 5 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.88377521 |
| 6 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.84253879 |
| 7 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.79612275 |
| 8 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.77670906 |
| 9 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.68473550 |
| 10 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.62768930 |
| 11 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.56143486 |
| 12 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.55697094 |
| 13 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.46418578 |
| 14 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.34358587 |
| 15 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.34126261 |
| 16 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.26309264 |
| 17 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.22829730 |
| 18 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.21177246 |
| 19 | GATA1_22025678_ChIP-Seq_K562_Human | 2.20220941 |
| 20 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.14106966 |
| 21 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.00722254 |
| 22 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.97836334 |
| 23 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.91878925 |
| 24 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.91512347 |
| 25 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.84329238 |
| 26 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.82637641 |
| 27 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.79871350 |
| 28 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.76293979 |
| 29 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.70765967 |
| 30 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.69956629 |
| 31 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.66779299 |
| 32 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.65473623 |
| 33 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.64397170 |
| 34 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.61530592 |
| 35 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.60726730 |
| 36 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.58527905 |
| 37 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.55111164 |
| 38 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.54383664 |
| 39 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.53540532 |
| 40 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.52460575 |
| 41 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.51119599 |
| 42 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.50696830 |
| 43 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.46432949 |
| 44 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.44692759 |
| 45 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.43110879 |
| 46 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.40298290 |
| 47 | CJUN_26792858_Chip-Seq_BT549_Human | 1.40063466 |
| 48 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.39480999 |
| 49 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.38177003 |
| 50 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.37705758 |
| 51 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.35709749 |
| 52 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.35709749 |
| 53 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.35671602 |
| 54 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.35529775 |
| 55 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.35017407 |
| 56 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.33319136 |
| 57 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.30610974 |
| 58 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.28987977 |
| 59 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.28788146 |
| 60 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.28008953 |
| 61 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.27814203 |
| 62 | TP53_16413492_ChIP-PET_HCT116_Human | 1.27453087 |
| 63 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.27257299 |
| 64 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.25614387 |
| 65 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.25481743 |
| 66 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.25073804 |
| 67 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.24914134 |
| 68 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.24814171 |
| 69 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.23560862 |
| 70 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.23560862 |
| 71 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.21473519 |
| 72 | FUS_26573619_Chip-Seq_HEK293_Human | 1.21433946 |
| 73 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.20672304 |
| 74 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.20546752 |
| 75 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.16729606 |
| 76 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.16450487 |
| 77 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.16102131 |
| 78 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.15805005 |
| 79 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.15728890 |
| 80 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.15454609 |
| 81 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.14658421 |
| 82 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.14120538 |
| 83 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.14076844 |
| 84 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.13178405 |
| 85 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.13014805 |
| 86 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.12991335 |
| 87 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.11725094 |
| 88 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.10556060 |
| 89 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.10470669 |
| 90 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.10178577 |
| 91 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.08278389 |
| 92 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.08196357 |
| 93 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.07737342 |
| 94 | SPI1_23127762_ChIP-Seq_K562_Human | 1.07251496 |
| 95 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.06930672 |
| 96 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.06930242 |
| 97 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.06717742 |
| 98 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.06649981 |
| 99 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.06589616 |
| 100 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.04917758 |
| 101 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.03622039 |
| 102 | P300_19829295_ChIP-Seq_ESCs_Human | 1.03506310 |
| 103 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.03293150 |
| 104 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.02695093 |
| 105 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.00190339 |
| 106 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.99883017 |
| 107 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.99850417 |
| 108 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.99219114 |
| 109 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.99104482 |
| 110 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.98957599 |
| 111 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.98953069 |
| 112 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.98872870 |
| 113 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.98466099 |
| 114 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.97932758 |
| 115 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.96876378 |
| 116 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.96853362 |
| 117 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.96236458 |
| 118 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.95733792 |
| 119 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.95029095 |
| 120 | EWS_26573619_Chip-Seq_HEK293_Human | 0.94064851 |
| 121 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.93199645 |
| 122 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.93050149 |
| 123 | ATF3_27146783_Chip-Seq_COLON_Human | 0.92617550 |
| 124 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.92475649 |
| 125 | GATA3_26560356_Chip-Seq_TH2_Human | 0.91576659 |
| 126 | GATA1_19941826_ChIP-Seq_K562_Human | 0.90923414 |
| 127 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.90734373 |
| 128 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.90606582 |
| 129 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.90603773 |
| 130 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.90575669 |
| 131 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.90399754 |
| 132 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.90297140 |
| 133 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.89076946 |
| 134 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.89051004 |
| 135 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.89006694 |
| 136 | RXR_22108803_ChIP-Seq_LS180_Human | 0.88199392 |
| 137 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.88066304 |
| 138 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.88038247 |
| 139 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.87688681 |
| 140 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.87556998 |
| 141 | MYB_26560356_Chip-Seq_TH2_Human | 0.87189658 |
| 142 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.86347724 |
| 143 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.86187194 |
| 144 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.85671095 |
| 145 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.85141747 |
| 146 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.84979818 |
| 147 | AR_25329375_ChIP-Seq_VCAP_Human | 0.84314314 |
| 148 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.84182878 |
| 149 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.84016743 |
| 150 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.83972152 |
| 151 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.83951689 |
| 152 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83921950 |
| 153 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.83914525 |
| 154 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 0.83751031 |
| 155 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.82904661 |
| 156 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.82749516 |
| 157 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.81446780 |
| 158 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.81032775 |
| 159 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.80959188 |
| 160 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.80692585 |
| 161 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.80683977 |
| 162 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.80291543 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000579_abnormal_nail_morphology | 4.49862127 |
| 2 | MP0003941_abnormal_skin_development | 3.87912528 |
| 3 | MP0002877_abnormal_melanocyte_morpholog | 3.02559186 |
| 4 | MP0010234_abnormal_vibrissa_follicle | 2.85368811 |
| 5 | MP0003183_abnormal_peptide_metabolism | 2.84780699 |
| 6 | MP0003436_decreased_susceptibility_to | 2.78085456 |
| 7 | MP0002254_reproductive_system_inflammat | 2.75227934 |
| 8 | MP0000566_synostosis | 2.70299324 |
| 9 | MP0001835_abnormal_antigen_presentation | 2.69614185 |
| 10 | MP0000762_abnormal_tongue_morphology | 2.56406009 |
| 11 | MP0005501_abnormal_skin_physiology | 2.56242192 |
| 12 | MP0003303_peritoneal_inflammation | 2.51773321 |
| 13 | MP0005058_abnormal_lysosome_morphology | 2.49950772 |
| 14 | MP0003724_increased_susceptibility_to | 2.38194806 |
| 15 | MP0004947_skin_inflammation | 2.26730297 |
| 16 | MP0002148_abnormal_hypersensitivity_rea | 2.25828584 |
| 17 | MP0000467_abnormal_esophagus_morphology | 2.24895882 |
| 18 | MP0004272_abnormal_basement_membrane | 2.18271783 |
| 19 | MP0002419_abnormal_innate_immunity | 2.13358504 |
| 20 | MP0003191_abnormal_cellular_cholesterol | 2.12927785 |
| 21 | MP0009053_abnormal_anal_canal | 2.12207739 |
| 22 | MP0003950_abnormal_plasma_membrane | 2.11680868 |
| 23 | MP0006082_CNS_inflammation | 2.09043918 |
| 24 | MP0005000_abnormal_immune_tolerance | 2.08989506 |
| 25 | MP0004185_abnormal_adipocyte_glucose | 2.08209926 |
| 26 | MP0003300_gastrointestinal_ulcer | 2.06751835 |
| 27 | MP0002138_abnormal_hepatobiliary_system | 2.05761609 |
| 28 | MP0009780_abnormal_chondrocyte_physiolo | 2.02849432 |
| 29 | MP0009785_altered_susceptibility_to | 2.02044126 |
| 30 | MP0008875_abnormal_xenobiotic_pharmacok | 1.98921723 |
| 31 | MP0003890_abnormal_embryonic-extraembry | 1.98239110 |
| 32 | MP0000569_abnormal_digit_pigmentation | 1.92534095 |
| 33 | MP0004510_myositis | 1.91751520 |
| 34 | MP0002139_abnormal_hepatobiliary_system | 1.87440921 |
| 35 | MP0005076_abnormal_cell_differentiation | 1.83086443 |
| 36 | MP0001533_abnormal_skeleton_physiology | 1.81170034 |
| 37 | MP0003453_abnormal_keratinocyte_physiol | 1.80455569 |
| 38 | MP0002693_abnormal_pancreas_physiology | 1.74780164 |
| 39 | MP0001790_abnormal_immune_system | 1.74328936 |
| 40 | MP0005387_immune_system_phenotype | 1.74328936 |
| 41 | MP0005085_abnormal_gallbladder_physiolo | 1.73734428 |
| 42 | MP0005275_abnormal_skin_tensile | 1.73593806 |
| 43 | MP0003172_abnormal_lysosome_physiology | 1.72053416 |
| 44 | MP0005360_urolithiasis | 1.68992951 |
| 45 | MP0005365_abnormal_bile_salt | 1.67932427 |
| 46 | MP0005670_abnormal_white_adipose | 1.65238682 |
| 47 | MP0005025_abnormal_response_to | 1.64851549 |
| 48 | MP0002006_tumorigenesis | 1.64487885 |
| 49 | MP0005257_abnormal_intraocular_pressure | 1.64131898 |
| 50 | MP0005666_abnormal_adipose_tissue | 1.63520801 |
| 51 | MP0003045_fibrosis | 1.63107122 |
| 52 | MP0010771_integument_phenotype | 1.61731849 |
| 53 | MP0000685_abnormal_immune_system | 1.61325275 |
| 54 | MP0002796_impaired_skin_barrier | 1.60136195 |
| 55 | MP0002452_abnormal_antigen_presenting | 1.57765537 |
| 56 | MP0003937_abnormal_limbs/digits/tail_de | 1.57020086 |
| 57 | MP0004782_abnormal_surfactant_physiolog | 1.50962767 |
| 58 | MP0002234_abnormal_pharynx_morphology | 1.50919777 |
| 59 | MP0000537_abnormal_urethra_morphology | 1.49816377 |
| 60 | MP0000013_abnormal_adipose_tissue | 1.49342539 |
| 61 | MP0002998_abnormal_bone_remodeling | 1.48857841 |
| 62 | MP0002723_abnormal_immune_serum | 1.46970919 |
| 63 | MP0002166_altered_tumor_susceptibility | 1.46545136 |
| 64 | MP0003315_abnormal_perineum_morphology | 1.45633986 |
| 65 | MP0000647_abnormal_sebaceous_gland | 1.44952845 |
| 66 | MP0005310_abnormal_salivary_gland | 1.44721765 |
| 67 | MP0005379_endocrine/exocrine_gland_phen | 1.43799830 |
| 68 | MP0004264_abnormal_extraembryonic_tissu | 1.43529530 |
| 69 | MP0005375_adipose_tissue_phenotype | 1.43094260 |
| 70 | MP0003566_abnormal_cell_adhesion | 1.41434790 |
| 71 | MP0003195_calcinosis | 1.38680380 |
| 72 | MP0010678_abnormal_skin_adnexa | 1.38168634 |
| 73 | MP0005023_abnormal_wound_healing | 1.36074671 |
| 74 | MP0005671_abnormal_response_to | 1.34143057 |
| 75 | MP0000427_abnormal_hair_cycle | 1.33202723 |
| 76 | MP0003283_abnormal_digestive_organ | 1.32081399 |
| 77 | MP0003448_altered_tumor_morphology | 1.31281918 |
| 78 | MP0000377_abnormal_hair_follicle | 1.28746825 |
| 79 | MP0001800_abnormal_humoral_immune | 1.28168053 |
| 80 | MP0001216_abnormal_epidermal_layer | 1.27604516 |
| 81 | MP0000383_abnormal_hair_follicle | 1.26711936 |
| 82 | MP0002697_abnormal_eye_size | 1.26203153 |
| 83 | MP0002009_preneoplasia | 1.25839220 |
| 84 | MP0003755_abnormal_palate_morphology | 1.25736866 |
| 85 | MP0003705_abnormal_hypodermis_morpholog | 1.24893873 |
| 86 | MP0002909_abnormal_adrenal_gland | 1.23997446 |
| 87 | MP0001845_abnormal_inflammatory_respons | 1.23954650 |
| 88 | MP0009840_abnormal_foam_cell | 1.20747809 |
| 89 | MP0001819_abnormal_immune_cell | 1.20134228 |
| 90 | MP0002282_abnormal_trachea_morphology | 1.19995122 |
| 91 | MP0001944_abnormal_pancreas_morphology | 1.18217788 |
| 92 | MP0010329_abnormal_lipoprotein_level | 1.16181055 |
| 93 | MP0002111_abnormal_tail_morphology | 1.15675318 |
| 94 | MP0010352_gastrointestinal_tract_polyps | 1.15244403 |
| 95 | MP0002420_abnormal_adaptive_immunity | 1.15209840 |
| 96 | MP0001853_heart_inflammation | 1.14801172 |
| 97 | MP0004130_abnormal_muscle_cell | 1.13974095 |
| 98 | MP0009384_cardiac_valve_regurgitation | 1.13602653 |
| 99 | MP0003136_yellow_coat_color | 1.12370897 |
| 100 | MP0005167_abnormal_blood-brain_barrier | 1.12362225 |
| 101 | MP0002060_abnormal_skin_morphology | 1.10658330 |
| 102 | MP0000003_abnormal_adipose_tissue | 1.09682521 |
| 103 | MP0010386_abnormal_urinary_bladder | 1.09648609 |
| 104 | MP0008469_abnormal_protein_level | 1.09057067 |
| 105 | MP0005464_abnormal_platelet_physiology | 1.08747061 |
| 106 | MP0002089_abnormal_postnatal_growth/wei | 1.05947630 |
| 107 | MP0009697_abnormal_copulation | 1.04735035 |
| 108 | MP0003011_delayed_dark_adaptation | 1.03594904 |
| 109 | MP0009764_decreased_sensitivity_to | 1.01958366 |
| 110 | MP0003075_altered_response_to | 1.01867061 |
| 111 | MP0003690_abnormal_glial_cell | 1.01528338 |
| 112 | MP0003828_pulmonary_edema | 1.01072268 |
| 113 | MP0003091_abnormal_cell_migration | 1.00695702 |
| 114 | MP0001666_abnormal_nutrient_absorption | 1.00693287 |
| 115 | MP0008961_abnormal_basal_metabolism | 0.99890104 |
| 116 | MP0003119_abnormal_digestive_system | 0.99689160 |
| 117 | MP0003252_abnormal_bile_duct | 0.98088702 |
| 118 | MP0002277_abnormal_respiratory_mucosa | 0.96977505 |
| 119 | MP0001286_abnormal_eye_development | 0.96613769 |
| 120 | MP0010155_abnormal_intestine_physiology | 0.94578932 |
| 121 | MP0001661_extended_life_span | 0.94357012 |
| 122 | MP0009278_abnormal_bone_marrow | 0.94346059 |
| 123 | MP0010368_abnormal_lymphatic_system | 0.92421083 |
| 124 | MP0002938_white_spotting | 0.92389582 |
| 125 | MP0001346_abnormal_lacrimal_gland | 0.92149528 |
| 126 | MP0001851_eye_inflammation | 0.91511061 |
| 127 | MP0002098_abnormal_vibrissa_morphology | 0.91033373 |
| 128 | MP0005197_abnormal_uvea_morphology | 0.89794056 |
| 129 | MP0001299_abnormal_eye_distance/ | 0.89190307 |
| 130 | MP0005390_skeleton_phenotype | 0.89050926 |
| 131 | MP0002971_abnormal_brown_adipose | 0.88722803 |
| 132 | MP0005334_abnormal_fat_pad | 0.88054752 |
| 133 | MP0002078_abnormal_glucose_homeostasis | 0.87082787 |
| 134 | MP0002896_abnormal_bone_mineralization | 0.87013468 |
| 135 | MP0006054_spinal_hemorrhage | 0.86927012 |
| 136 | MP0002928_abnormal_bile_duct | 0.86847507 |
| 137 | MP0010030_abnormal_orbit_morphology | 0.86807760 |
| 138 | MP0000516_abnormal_urinary_system | 0.86688888 |
| 139 | MP0005367_renal/urinary_system_phenotyp | 0.86688888 |
| 140 | MP0001340_abnormal_eyelid_morphology | 0.86454973 |
| 141 | MP0002405_respiratory_system_inflammati | 0.86370092 |
| 142 | MP0003868_abnormal_feces_composition | 0.86245390 |
| 143 | MP0003718_maternal_effect | 0.86213090 |
| 144 | MP0009250_abnormal_appendicular_skeleto | 0.85895146 |
| 145 | MP0005535_abnormal_body_temperature | 0.85773403 |
| 146 | MP0002233_abnormal_nose_morphology | 0.85256299 |
| 147 | MP0000627_abnormal_mammary_gland | 0.84864779 |
| 148 | MP0005332_abnormal_amino_acid | 0.84200451 |
| 149 | MP0000371_diluted_coat_color | 0.81572127 |
| 150 | MP0002092_abnormal_eye_morphology | 0.80712257 |
| 151 | MP0004043_abnormal_pH_regulation | 0.80521489 |
| 152 | MP0000858_altered_metastatic_potential | 0.79544801 |
| 153 | MP0008004_abnormal_stomach_pH | 0.79411604 |
| 154 | MP0004019_abnormal_vitamin_homeostasis | 0.78982031 |
| 155 | MP0002168_other_aberrant_phenotype | 0.78346032 |
| 156 | MP0003795_abnormal_bone_structure | 0.75677282 |
| 157 | MP0005164_abnormal_response_to | 0.75493807 |
| 158 | MP0003122_maternal_imprinting | 0.75022259 |
| 159 | MP0000432_abnormal_head_morphology | 0.74183570 |
| 160 | MP0000538_abnormal_urinary_bladder | 0.73940448 |
| 161 | MP0000462_abnormal_digestive_system | 0.72983187 |
| 162 | MP0001849_ear_inflammation | 0.72609002 |
| 163 | MP0004133_heterotaxia | 0.71454924 |
| 164 | MP0002084_abnormal_developmental_patter | 0.66224135 |
| 165 | MP0009931_abnormal_skin_appearance | 0.64885230 |
| 166 | MP0004885_abnormal_endolymph | 0.64414744 |
| 167 | MP0000367_abnormal_coat/_hair | 0.64232413 |
| 168 | MP0005409_darkened_coat_color | 0.60992267 |
| 169 | MP0001191_abnormal_skin_condition | 0.60715304 |
| 170 | MP0002876_abnormal_thyroid_physiology | 0.59615205 |
| 171 | MP0001243_abnormal_dermal_layer | 0.58412111 |
| 172 | MP0002109_abnormal_limb_morphology | 0.58327410 |
| 173 | MP0005623_abnormal_meninges_morphology | 0.57981466 |
| 174 | MP0004197_abnormal_fetal_growth/weight/ | 0.57754623 |
| 175 | MP0003693_abnormal_embryo_hatching | 0.57458174 |
| 176 | MP0002160_abnormal_reproductive_system | 0.57322546 |
| 177 | MP0005395_other_phenotype | 0.57075559 |
| 178 | MP0005187_abnormal_penis_morphology | 0.54829018 |
| 179 | MP0003936_abnormal_reproductive_system | 0.54771975 |
| 180 | MP0003935_abnormal_craniofacial_develop | 0.54648401 |
| 181 | MP0005508_abnormal_skeleton_morphology | 0.53979376 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of nail color (HP:0100643) | 6.11512883 |
| 2 | Eczematoid dermatitis (HP:0000976) | 5.29138952 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 4.60117772 |
| 4 | Recurrent abscess formation (HP:0002722) | 4.45493842 |
| 5 | Palmar hyperkeratosis (HP:0010765) | 4.42807908 |
| 6 | Onycholysis (HP:0001806) | 4.18096402 |
| 7 | Alopecia of scalp (HP:0002293) | 4.12967884 |
| 8 | Fragile nails (HP:0001808) | 4.12441326 |
| 9 | Milia (HP:0001056) | 4.00942272 |
| 10 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.91488500 |
| 11 | Increased cerebral lipofuscin (HP:0011813) | 3.81808778 |
| 12 | Systemic lupus erythematosus (HP:0002725) | 3.67967817 |
| 13 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.53666156 |
| 14 | Right ventricular cardiomyopathy (HP:0011663) | 3.52493591 |
| 15 | Hematochezia (HP:0002573) | 3.47163996 |
| 16 | Dysostosis multiplex (HP:0000943) | 3.39054316 |
| 17 | Insulin-resistant diabetes mellitus (HP:0000831) | 3.30587563 |
| 18 | Abnormality of glycolipid metabolism (HP:0010969) | 3.26430697 |
| 19 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.26430697 |
| 20 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.26430697 |
| 21 | Hypoglycemic seizures (HP:0002173) | 3.21983037 |
| 22 | Myocardial infarction (HP:0001658) | 3.18634977 |
| 23 | Abnormality of macrophages (HP:0004311) | 3.17340416 |
| 24 | Mucopolysacchariduria (HP:0008155) | 3.14357032 |
| 25 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.14357032 |
| 26 | Gingivitis (HP:0000230) | 3.08491344 |
| 27 | Interstitial pulmonary disease (HP:0006530) | 3.05282045 |
| 28 | Glomerulonephritis (HP:0000099) | 3.02648876 |
| 29 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.96641261 |
| 30 | Increased IgE level (HP:0003212) | 2.95876008 |
| 31 | Symptomatic seizures (HP:0011145) | 2.95474205 |
| 32 | Thick nail (HP:0001805) | 2.94588625 |
| 33 | Orchitis (HP:0100796) | 2.91333231 |
| 34 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.90243524 |
| 35 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.90243524 |
| 36 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.90243524 |
| 37 | Hypotrichosis (HP:0001006) | 2.89151499 |
| 38 | Abnormality of the nasal septum (HP:0000419) | 2.88944536 |
| 39 | Periodontitis (HP:0000704) | 2.86964519 |
| 40 | Nail dystrophy (HP:0008404) | 2.86951523 |
| 41 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.86124900 |
| 42 | Atrophic scars (HP:0001075) | 2.85887691 |
| 43 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.84271785 |
| 44 | Tetraparesis (HP:0002273) | 2.84025639 |
| 45 | Pterygium (HP:0001059) | 2.81036145 |
| 46 | Abnormality of secondary sexual hair (HP:0009888) | 2.79354804 |
| 47 | Abnormality of the axillary hair (HP:0100134) | 2.79354804 |
| 48 | Mediastinal lymphadenopathy (HP:0100721) | 2.78095857 |
| 49 | Deep venous thrombosis (HP:0002625) | 2.76341317 |
| 50 | Vacuolated lymphocytes (HP:0001922) | 2.75569096 |
| 51 | Hypobetalipoproteinemia (HP:0003563) | 2.73862787 |
| 52 | Autoimmune thrombocytopenia (HP:0001973) | 2.73277674 |
| 53 | Oral leukoplakia (HP:0002745) | 2.73144351 |
| 54 | Hypoglycemic coma (HP:0001325) | 2.71342579 |
| 55 | Vascular calcification (HP:0004934) | 2.68048411 |
| 56 | Prolonged partial thromboplastin time (HP:0003645) | 2.67613330 |
| 57 | Corneal erosion (HP:0200020) | 2.63514704 |
| 58 | Axonal loss (HP:0003447) | 2.59619492 |
| 59 | Retrobulbar optic neuritis (HP:0100654) | 2.57750958 |
| 60 | Optic neuritis (HP:0100653) | 2.57750958 |
| 61 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.57617249 |
| 62 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 2.56836366 |
| 63 | Parakeratosis (HP:0001036) | 2.56108231 |
| 64 | Erythroderma (HP:0001019) | 2.55162117 |
| 65 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.52958477 |
| 66 | Hyperglycemia (HP:0003074) | 2.49773416 |
| 67 | Retinal atrophy (HP:0001105) | 2.48987211 |
| 68 | Sparse eyelashes (HP:0000653) | 2.46970078 |
| 69 | Osteolytic defects of the hand bones (HP:0009699) | 2.46071874 |
| 70 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.46071874 |
| 71 | Natal tooth (HP:0000695) | 2.44452044 |
| 72 | Recurrent skin infections (HP:0001581) | 2.44081686 |
| 73 | Cardiovascular calcification (HP:0011915) | 2.43015680 |
| 74 | Myositis (HP:0100614) | 2.42491009 |
| 75 | Abnormality of proline metabolism (HP:0010907) | 2.41700292 |
| 76 | Hydroxyprolinuria (HP:0003080) | 2.41700292 |
| 77 | Hypoplastic labia majora (HP:0000059) | 2.36186318 |
| 78 | Abnormality of carpal bone ossification (HP:0006257) | 2.35957308 |
| 79 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.35419602 |
| 80 | Absent eyelashes (HP:0000561) | 2.35315612 |
| 81 | Nephritis (HP:0000123) | 2.31983072 |
| 82 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.29473286 |
| 83 | Woolly hair (HP:0002224) | 2.28070186 |
| 84 | Intrahepatic cholestasis (HP:0001406) | 2.25151200 |
| 85 | Disinhibition (HP:0000734) | 2.23887841 |
| 86 | Pulmonary infiltrates (HP:0002113) | 2.21834064 |
| 87 | Recurrent fungal infections (HP:0002841) | 2.20960972 |
| 88 | Gastrointestinal infarctions (HP:0005244) | 2.19878620 |
| 89 | Acanthosis nigricans (HP:0000956) | 2.18737930 |
| 90 | Ectropion (HP:0000656) | 2.18715558 |
| 91 | Hypergammaglobulinemia (HP:0010702) | 2.18604851 |
| 92 | Conjugated hyperbilirubinemia (HP:0002908) | 2.18205747 |
| 93 | Vasculitis (HP:0002633) | 2.17506214 |
| 94 | Dry hair (HP:0011359) | 2.16826529 |
| 95 | Premature loss of primary teeth (HP:0006323) | 2.15393872 |
| 96 | Hypohidrosis (HP:0000966) | 2.15147338 |
| 97 | Popliteal pterygium (HP:0009756) | 2.14593028 |
| 98 | Follicular hyperkeratosis (HP:0007502) | 2.10608796 |
| 99 | Pili torti (HP:0003777) | 2.10380207 |
| 100 | Abnormality of the labia majora (HP:0012881) | 2.09701953 |
| 101 | Coronal craniosynostosis (HP:0004440) | 2.09138826 |
| 102 | Abnormality of the middle phalanges of the toes (HP:0010183) | 2.08517947 |
| 103 | Peritonitis (HP:0002586) | 2.02427149 |
| 104 | Basal ganglia calcification (HP:0002135) | 2.02375723 |
| 105 | Neonatal short-limb short stature (HP:0008921) | 2.02116910 |
| 106 | Prostate neoplasm (HP:0100787) | 2.01919984 |
| 107 | Advanced eruption of teeth (HP:0006288) | 2.01270389 |
| 108 | Cerebral aneurysm (HP:0004944) | 2.00885421 |
| 109 | Lip pit (HP:0100267) | 2.00708948 |
| 110 | Increased CSF protein (HP:0002922) | 2.00191411 |
| 111 | Ridged nail (HP:0001807) | 1.99513825 |
| 112 | Insulin resistance (HP:0000855) | 1.99377412 |
| 113 | Abnormal hair laboratory examination (HP:0003328) | 1.97044395 |
| 114 | Progressive visual loss (HP:0000529) | 1.94803227 |
| 115 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.93367003 |
| 116 | Labial hypoplasia (HP:0000066) | 1.93178239 |
| 117 | Abnormality of complement system (HP:0005339) | 1.92929143 |
| 118 | Palmoplantar keratoderma (HP:0000982) | 1.91692600 |
| 119 | Peripheral demyelination (HP:0011096) | 1.91445909 |
| 120 | Hypoplasia of dental enamel (HP:0006297) | 1.91277589 |
| 121 | Arterial thrombosis (HP:0004420) | 1.90900201 |
| 122 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 1.90554945 |
| 123 | Abnormal ossification of hand bones (HP:0005921) | 1.90049307 |
| 124 | Abnormal hand bone ossification (HP:0010660) | 1.88105319 |
| 125 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.87257528 |
| 126 | Absent hair (HP:0002298) | 1.86409129 |
| 127 | Breast hypoplasia (HP:0003187) | 1.85156884 |
| 128 | Bone pain (HP:0002653) | 1.85120634 |
| 129 | Colitis (HP:0002583) | 1.84421525 |
| 130 | Septate vagina (HP:0001153) | 1.83883512 |
| 131 | Complement deficiency (HP:0004431) | 1.83734127 |
| 132 | Short humerus (HP:0005792) | 1.83422275 |
| 133 | Hypoplastic female external genitalia (HP:0012815) | 1.83071494 |
| 134 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.82399761 |
| 135 | Amyloidosis (HP:0011034) | 1.82339900 |
| 136 | Polygenic inheritance (HP:0010982) | 1.82285573 |
| 137 | Small epiphyses (HP:0010585) | 1.79395701 |
| 138 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.79340509 |
| 139 | Cellulitis (HP:0100658) | 1.79105834 |
| 140 | Hypolipoproteinemia (HP:0010981) | 1.78730988 |
| 141 | Cortical dysplasia (HP:0002539) | 1.78187774 |
| 142 | Oligomenorrhea (HP:0000876) | 1.77685097 |
| 143 | Abnormal blistering of the skin (HP:0008066) | 1.77357946 |
| 144 | Recurrent viral infections (HP:0004429) | 1.76576007 |
| 145 | Esophageal varix (HP:0002040) | 1.76568125 |
| 146 | Short tibia (HP:0005736) | 1.76199830 |
| 147 | Recurrent corneal erosions (HP:0000495) | 1.74642436 |
| 148 | Aplasia/hypoplasia of the humerus (HP:0006507) | 1.74191225 |
| 149 | Abnormality of the gastric mucosa (HP:0004295) | 1.74139275 |
| 150 | Short hallux (HP:0010109) | 1.72791555 |
| 151 | Bifid scrotum (HP:0000048) | 1.72269093 |
| 152 | Esophageal atresia (HP:0002032) | 1.71198391 |
| 153 | Hypoplasia of the uterus (HP:0000013) | 1.69879555 |
| 154 | Progressive neurologic deterioration (HP:0002344) | 1.69813731 |
| 155 | Villous atrophy (HP:0011473) | 1.69114279 |
| 156 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.69114279 |
| 157 | Plantar hyperkeratosis (HP:0007556) | 1.69022892 |
| 158 | Abnormality of the pericardium (HP:0001697) | 1.68786657 |
| 159 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.67177721 |
| 160 | Stomatitis (HP:0010280) | 1.67087074 |
| 161 | Vertebral clefting (HP:0008428) | 1.66992941 |
| 162 | Bone cyst (HP:0012062) | 1.66737328 |
| 163 | Fragile skin (HP:0001030) | 1.66714548 |
| 164 | Episodic fever (HP:0001954) | 1.63999307 |
| 165 | Mitral stenosis (HP:0001718) | 1.63786273 |
| 166 | Pustule (HP:0200039) | 1.63767211 |
| 167 | Laryngomalacia (HP:0001601) | 1.63228733 |
| 168 | Palmoplantar hyperkeratosis (HP:0000972) | 1.63112627 |
| 169 | Blepharitis (HP:0000498) | 1.62129552 |
| 170 | Skin nodule (HP:0200036) | 1.61844192 |
| 171 | Hemorrhage of the eye (HP:0011885) | 1.61144143 |
| 172 | Osteomyelitis (HP:0002754) | 1.60086504 |
| 173 | Glucose intolerance (HP:0000833) | 1.59635146 |
| 174 | Brittle hair (HP:0002299) | 1.59214529 |
| 175 | Duplicated collecting system (HP:0000081) | 1.58671407 |
| 176 | Aplasia cutis congenita (HP:0001057) | 1.58610610 |
| 177 | Deviation of the thumb (HP:0009603) | 1.57226422 |
| 178 | Xerostomia (HP:0000217) | 1.57083590 |
| 179 | Anonychia (HP:0001798) | 1.56999709 |
| 180 | Ureteral duplication (HP:0000073) | 1.56489525 |
| 181 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.55965206 |
| 182 | Epidermoid cyst (HP:0200040) | 1.55943276 |
| 183 | Sparse scalp hair (HP:0002209) | 1.55893008 |
| 184 | Macroorchidism (HP:0000053) | 1.55817629 |
| 185 | Oligodontia (HP:0000677) | 1.55597978 |
| 186 | Depressed nasal tip (HP:0000437) | 1.53923804 |
| 187 | Abnormality of the 2nd finger (HP:0004100) | 1.53301707 |
| 188 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.52898185 |
| 189 | Abnormality of placental membranes (HP:0011409) | 1.52460680 |
| 190 | Amniotic constriction ring (HP:0009775) | 1.52460680 |
| 191 | Rickets (HP:0002748) | 1.52078687 |
| 192 | Erythema (HP:0010783) | 1.51539470 |
| 193 | Fair hair (HP:0002286) | 1.51218407 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 3.76680657 |
| 2 | INSRR | 3.63847009 |
| 3 | MAPK15 | 3.21210141 |
| 4 | ERN1 | 3.13898595 |
| 5 | IRAK3 | 3.03320500 |
| 6 | LATS1 | 2.81738876 |
| 7 | WEE1 | 2.74500290 |
| 8 | TSSK6 | 2.65714636 |
| 9 | PNCK | 2.59311860 |
| 10 | STK38L | 2.55206735 |
| 11 | BRSK2 | 2.50127346 |
| 12 | TBK1 | 2.43248403 |
| 13 | RIPK4 | 2.41232053 |
| 14 | TYK2 | 2.37185308 |
| 15 | AKT3 | 2.19830668 |
| 16 | LATS2 | 2.16051306 |
| 17 | TAOK3 | 2.11747259 |
| 18 | ERBB4 | 2.10265304 |
| 19 | EPHA3 | 2.06950921 |
| 20 | JAK1 | 2.06346756 |
| 21 | FRK | 2.05421929 |
| 22 | IRAK4 | 2.03889599 |
| 23 | CAMK1D | 2.03131222 |
| 24 | RIPK1 | 2.01324822 |
| 25 | FGFR3 | 1.99727138 |
| 26 | CHUK | 1.98033443 |
| 27 | IKBKB | 1.92375631 |
| 28 | STK24 | 1.82690066 |
| 29 | EIF2AK3 | 1.79936105 |
| 30 | IRAK1 | 1.78694038 |
| 31 | JAK3 | 1.75888094 |
| 32 | TGFBR2 | 1.72770625 |
| 33 | TRIB3 | 1.68911933 |
| 34 | PDK2 | 1.66829586 |
| 35 | FGFR4 | 1.65126963 |
| 36 | STK39 | 1.63507655 |
| 37 | EPHB1 | 1.62997140 |
| 38 | MST1R | 1.62280117 |
| 39 | WNK4 | 1.60310312 |
| 40 | IKBKE | 1.58110137 |
| 41 | MKNK2 | 1.57833854 |
| 42 | ACVR1B | 1.57125240 |
| 43 | HIPK2 | 1.54950817 |
| 44 | MAP3K12 | 1.47555541 |
| 45 | PASK | 1.42118882 |
| 46 | MAP3K9 | 1.41463666 |
| 47 | CASK | 1.41248262 |
| 48 | CAMK1G | 1.39972992 |
| 49 | MAP3K13 | 1.36452462 |
| 50 | TRIM28 | 1.31624607 |
| 51 | PTK6 | 1.26840080 |
| 52 | TGFBR1 | 1.26700253 |
| 53 | MAP3K2 | 1.26281577 |
| 54 | MST4 | 1.21785599 |
| 55 | MAP3K1 | 1.18982594 |
| 56 | IRAK2 | 1.17829366 |
| 57 | CSK | 1.17277358 |
| 58 | JAK2 | 1.14551695 |
| 59 | FGFR1 | 1.13155282 |
| 60 | BLK | 1.12983114 |
| 61 | NUAK1 | 1.08894675 |
| 62 | ZAK | 1.05361055 |
| 63 | MAP3K3 | 1.04108875 |
| 64 | FER | 1.03489032 |
| 65 | MKNK1 | 0.98674603 |
| 66 | PIK3CA | 0.95580474 |
| 67 | ERBB3 | 0.94691619 |
| 68 | NEK1 | 0.93138118 |
| 69 | SIK1 | 0.92787697 |
| 70 | LMTK2 | 0.92216982 |
| 71 | TAF1 | 0.91915195 |
| 72 | PLK3 | 0.91776973 |
| 73 | PDGFRA | 0.91095349 |
| 74 | RPS6KA4 | 0.90950774 |
| 75 | TTK | 0.90812952 |
| 76 | NTRK1 | 0.89629767 |
| 77 | PRKAA2 | 0.89590827 |
| 78 | FLT3 | 0.85875502 |
| 79 | PAK4 | 0.84528274 |
| 80 | PLK4 | 0.84422514 |
| 81 | CSF1R | 0.84341474 |
| 82 | ZAP70 | 0.83397855 |
| 83 | PDGFRB | 0.80591886 |
| 84 | NEK9 | 0.80409249 |
| 85 | MAP2K2 | 0.79883030 |
| 86 | EIF2AK1 | 0.79185378 |
| 87 | MET | 0.77281915 |
| 88 | MAPKAPK3 | 0.76781217 |
| 89 | SRPK1 | 0.74824267 |
| 90 | DYRK1B | 0.72767579 |
| 91 | WNK3 | 0.71329991 |
| 92 | PAK2 | 0.67532133 |
| 93 | GSK3A | 0.67500544 |
| 94 | BMPR1B | 0.65189882 |
| 95 | RET | 0.63744973 |
| 96 | BUB1 | 0.63503984 |
| 97 | PBK | 0.63337462 |
| 98 | ABL2 | 0.63094054 |
| 99 | BRD4 | 0.62614482 |
| 100 | HCK | 0.61948028 |
| 101 | BMPR2 | 0.59631140 |
| 102 | BMX | 0.59354549 |
| 103 | EIF2AK2 | 0.58218087 |
| 104 | CSNK1G1 | 0.58175663 |
| 105 | MAP3K10 | 0.58105317 |
| 106 | MYLK | 0.57606338 |
| 107 | BCR | 0.56614804 |
| 108 | IGF1R | 0.55628292 |
| 109 | PIK3CG | 0.55285198 |
| 110 | RPS6KA2 | 0.55066434 |
| 111 | CDK6 | 0.54594484 |
| 112 | MAPKAPK2 | 0.53721126 |
| 113 | MAPKAPK5 | 0.53439568 |
| 114 | ITK | 0.53059353 |
| 115 | KIT | 0.52922354 |
| 116 | EGFR | 0.52154497 |
| 117 | BRSK1 | 0.52118583 |
| 118 | MELK | 0.51894631 |
| 119 | PLK1 | 0.51170074 |
| 120 | TRPM7 | 0.50808014 |
| 121 | LCK | 0.48698165 |
| 122 | ADRBK1 | 0.48279911 |
| 123 | SCYL2 | 0.48222369 |
| 124 | EPHA2 | 0.48122206 |
| 125 | CDK7 | 0.47518772 |
| 126 | FGFR2 | 0.47495043 |
| 127 | SYK | 0.47230850 |
| 128 | PTK2 | 0.47047133 |
| 129 | CSNK1A1L | 0.45568431 |
| 130 | PRKCI | 0.44757948 |
| 131 | STK3 | 0.44596152 |
| 132 | NEK6 | 0.43639236 |
| 133 | MARK3 | 0.43389265 |
| 134 | CDK12 | 0.42994189 |
| 135 | PLK2 | 0.42694307 |
| 136 | DMPK | 0.42294848 |
| 137 | STK10 | 0.41487380 |
| 138 | OXSR1 | 0.41039481 |
| 139 | EPHB2 | 0.39899382 |
| 140 | INSR | 0.39805770 |
| 141 | GRK7 | 0.39296980 |
| 142 | ABL1 | 0.38365025 |
| 143 | MAP4K1 | 0.38258606 |
| 144 | CSNK1G2 | 0.38083608 |
| 145 | GRK1 | 0.37661245 |
| 146 | PRKCE | 0.37428635 |
| 147 | CDK9 | 0.36237874 |
| 148 | BRAF | 0.34600568 |
| 149 | VRK1 | 0.34437268 |
| 150 | CSNK1E | 0.34424487 |
| 151 | CSNK1G3 | 0.34247268 |
| 152 | MTOR | 0.34153439 |
| 153 | STK16 | 0.33835003 |
| 154 | PIM2 | 0.33670205 |
| 155 | PRKCD | 0.33375366 |
| 156 | LYN | 0.33047490 |
| 157 | ROCK1 | 0.32822125 |
| 158 | TEC | 0.32699524 |
| 159 | TESK1 | 0.32203758 |
| 160 | SGK1 | 0.32135949 |
| 161 | MOS | 0.31885982 |
| 162 | MAP2K1 | 0.31318512 |
| 163 | NEK2 | 0.30879936 |
| 164 | DYRK3 | 0.30622502 |
| 165 | RPS6KA1 | 0.30455325 |
| 166 | NLK | 0.30263902 |
| 167 | MAP4K2 | 0.30165376 |
| 168 | MAP2K3 | 0.29827716 |
| 169 | DDR2 | 0.29742612 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.92759490 |
| 2 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.85970681 |
| 3 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.83390153 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.48246277 |
| 5 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.25867352 |
| 6 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.13786823 |
| 7 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.13034536 |
| 8 | Legionellosis_Homo sapiens_hsa05134 | 2.12109897 |
| 9 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.09435509 |
| 10 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.08824196 |
| 11 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.08180632 |
| 12 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.06925960 |
| 13 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.02350477 |
| 14 | Lysosome_Homo sapiens_hsa04142 | 2.01535634 |
| 15 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.99938852 |
| 16 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.97534111 |
| 17 | Retinol metabolism_Homo sapiens_hsa00830 | 1.90296235 |
| 18 | Pertussis_Homo sapiens_hsa05133 | 1.87597474 |
| 19 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.86142300 |
| 20 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.85838010 |
| 21 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.82624601 |
| 22 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.75167408 |
| 23 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.72369166 |
| 24 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.70735829 |
| 25 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.65629839 |
| 26 | Tuberculosis_Homo sapiens_hsa05152 | 1.64049251 |
| 27 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.63911995 |
| 28 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.63752221 |
| 29 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.63622600 |
| 30 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.59889595 |
| 31 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.58271841 |
| 32 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.56288972 |
| 33 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.55099199 |
| 34 | Histidine metabolism_Homo sapiens_hsa00340 | 1.53917566 |
| 35 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.49205497 |
| 36 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.47503187 |
| 37 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.46041267 |
| 38 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.44775953 |
| 39 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.44471524 |
| 40 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.42235608 |
| 41 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.39438458 |
| 42 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.38010724 |
| 43 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.37459027 |
| 44 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.36963171 |
| 45 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.36561742 |
| 46 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.36028704 |
| 47 | Malaria_Homo sapiens_hsa05144 | 1.35356756 |
| 48 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.35212425 |
| 49 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.33322937 |
| 50 | Influenza A_Homo sapiens_hsa05164 | 1.32727017 |
| 51 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.32571701 |
| 52 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.32267205 |
| 53 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.29263253 |
| 54 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.29172987 |
| 55 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.28665057 |
| 56 | Measles_Homo sapiens_hsa05162 | 1.27632732 |
| 57 | Allograft rejection_Homo sapiens_hsa05330 | 1.27015174 |
| 58 | Prion diseases_Homo sapiens_hsa05020 | 1.26460419 |
| 59 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.26027828 |
| 60 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.25654272 |
| 61 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.24558147 |
| 62 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.24362101 |
| 63 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.24148940 |
| 64 | Other glycan degradation_Homo sapiens_hsa00511 | 1.23052354 |
| 65 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.22646392 |
| 66 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.22606224 |
| 67 | Apoptosis_Homo sapiens_hsa04210 | 1.22437850 |
| 68 | Phagosome_Homo sapiens_hsa04145 | 1.21318867 |
| 69 | Insulin resistance_Homo sapiens_hsa04931 | 1.21305864 |
| 70 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.19316373 |
| 71 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.14951197 |
| 72 | Bile secretion_Homo sapiens_hsa04976 | 1.14577183 |
| 73 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.13518691 |
| 74 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.13364096 |
| 75 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.13168621 |
| 76 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.12909225 |
| 77 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.12640293 |
| 78 | Protein export_Homo sapiens_hsa03060 | 1.12416613 |
| 79 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.10180049 |
| 80 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.08949386 |
| 81 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.07520821 |
| 82 | Salmonella infection_Homo sapiens_hsa05132 | 1.07102964 |
| 83 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.06996555 |
| 84 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.05828641 |
| 85 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.05692484 |
| 86 | Amoebiasis_Homo sapiens_hsa05146 | 1.05677103 |
| 87 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.04749634 |
| 88 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.04125269 |
| 89 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.03853541 |
| 90 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.03613374 |
| 91 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.02853794 |
| 92 | Hepatitis C_Homo sapiens_hsa05160 | 1.01092550 |
| 93 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.00634990 |
| 94 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.00576751 |
| 95 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.00118277 |
| 96 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.00099455 |
| 97 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.98832962 |
| 98 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.98630045 |
| 99 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.98357481 |
| 100 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.97997655 |
| 101 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.95950667 |
| 102 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.95915948 |
| 103 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.95172856 |
| 104 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.94611695 |
| 105 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.94260488 |
| 106 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.92273629 |
| 107 | Circadian rhythm_Homo sapiens_hsa04710 | 0.90435545 |
| 108 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.88535744 |
| 109 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.87962414 |
| 110 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.86632317 |
| 111 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.85143172 |
| 112 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.84780705 |
| 113 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.84094681 |
| 114 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.83934492 |
| 115 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.80677829 |
| 116 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.80400138 |
| 117 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.79551383 |
| 118 | Hepatitis B_Homo sapiens_hsa05161 | 0.78274017 |
| 119 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.75900504 |
| 120 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.75867646 |
| 121 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.75563532 |
| 122 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.74958466 |
| 123 | Peroxisome_Homo sapiens_hsa04146 | 0.74360636 |
| 124 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.73729325 |
| 125 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.73545320 |
| 126 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.73046046 |
| 127 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.71384798 |
| 128 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.70455626 |
| 129 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.69746987 |
| 130 | ABC transporters_Homo sapiens_hsa02010 | 0.69235805 |
| 131 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.68913517 |
| 132 | Asthma_Homo sapiens_hsa05310 | 0.67326851 |
| 133 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.66960776 |
| 134 | Tight junction_Homo sapiens_hsa04530 | 0.64724734 |
| 135 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.64546281 |
| 136 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.63595528 |
| 137 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.62524511 |
| 138 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.62044921 |
| 139 | Viral myocarditis_Homo sapiens_hsa05416 | 0.61653395 |
| 140 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.61235590 |
| 141 | Shigellosis_Homo sapiens_hsa05131 | 0.59852065 |
| 142 | Basal transcription factors_Homo sapiens_hsa03022 | 0.59162804 |
| 143 | Adherens junction_Homo sapiens_hsa04520 | 0.58990827 |
| 144 | Bladder cancer_Homo sapiens_hsa05219 | 0.58469258 |
| 145 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.56816778 |
| 146 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.56076580 |
| 147 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.55737724 |
| 148 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.55674828 |
| 149 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.55560564 |
| 150 | Metabolic pathways_Homo sapiens_hsa01100 | 0.53714691 |
| 151 | Prostate cancer_Homo sapiens_hsa05215 | 0.53226541 |
| 152 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.52953752 |
| 153 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.52723216 |
| 154 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.52499536 |
| 155 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.52058066 |
| 156 | Axon guidance_Homo sapiens_hsa04360 | 0.51078222 |
| 157 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.51065279 |
| 158 | Insulin secretion_Homo sapiens_hsa04911 | 0.50097529 |
| 159 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.50085447 |
| 160 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.49654901 |
| 161 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.48563185 |
| 162 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.48227327 |
| 163 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.47602378 |
| 164 | RNA transport_Homo sapiens_hsa03013 | 0.47319181 |
| 165 | Mineral absorption_Homo sapiens_hsa04978 | 0.47251199 |
| 166 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.47096419 |
| 167 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.47015958 |
| 168 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.45735450 |
| 169 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.45604759 |
| 170 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.45198135 |
| 171 | Endocytosis_Homo sapiens_hsa04144 | 0.44505248 |
| 172 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.44017349 |
| 173 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.43990079 |
| 174 | Galactose metabolism_Homo sapiens_hsa00052 | 0.43087717 |
| 175 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.42926333 |
| 176 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.42385699 |
| 177 | Platelet activation_Homo sapiens_hsa04611 | 0.40613156 |
| 178 | Focal adhesion_Homo sapiens_hsa04510 | 0.39254572 |
| 179 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.39052341 |
| 180 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.37883120 |
| 181 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.36365068 |
| 182 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.35249246 |
| 183 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.35199362 |

